Find a Pharmacy
Vertice Login
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe

WCRI Publishes 2026 Medical Price Index

The report compares prices paid for medical services across 36 states from 2008 to 2025.
Read More →
June 1, 2026

California Publishes Independent Medical Review Report

Pharmaceutical requests represented 30.6% of all treatment requests submitted for IMR, a modest decline from 32.7% in 2024.
Read More →
May 25, 2026

Georgia Enacts Regulations for Psychedelic Clinics

The Georgia Composite Medical Board will issue rules and regulations for clinics administering psychedelic-assisted therapies by December 31, 2026.
Read More →
May 25, 2026

Colorado Could Expand Cancer Coverage for Firefighters

Senate Bill 184 passed both chambers and now sits with Governor Polis.
Read More →
May 25, 2026

WCRI Publishes Interstate Variation and Trends Report on Drug Payments

Dermatological agents remained a significant cost driver, in part due to physician dispensing and delivery pharmacies, which accounted for a significant number of high-cost transactions.
Read More →
May 25, 2026

Montana Proposes Updates to Formulary and Fee Schedule, Requesting Stakeholder Feedback

A remote hearing will be held on May 28th, with comments accepted through June 5th. If enacted, changes will take effect July 1st.
Read More →
May 18, 2026

Oklahoma Enacts Law for Ibogaine Clinical Trials

Effective November 1st, the Department of Health can enter into contracts with drug developers to conduct ibogaine clinical trials.
Read More →
May 18, 2026

Connecticut Could Soon Expand Psychedelic Pilot Program

Previously limited to veterans and other specific populations, the bill could apply to any adult that meets clinical eligibility criteria.
Read More →
May 18, 2026

Louisiana Considers Psychedelic-Assisted Therapy Program

Psilocybin and ibogaine clinical trials would target opioid use disorder and treatment-resistant mental health conditions.
Read More →
May 18, 2026
1 4 5 6 7 8 58

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

Common Exceptions: The Rising Incidence of Complex Claims in Workers’ Compensation

Understanding the factors that drive longer claim duration and higher costs.
Read More

California to Expedite Research Around Schedule I & II Drugs

Assembly Bill 1103 was enacted, allowing for the Research Advisory Panel to expedite the review and approval of research applications.
Read More

Healthe Leaders Share Insights

CEO Daryl Corr and SVP Todd Piscoitti were featured in WorkCompWire’s Leaders Speak series, while VP of Clinical Services, Silvia Sacalis’ recaps her National Comp presentation.
Read More

INFOGRAPHIC: Current State of Complex Claims in Workers’ Comp

Statistics from recent studies across the industry shed light on complex claims in workers' compensation.
Read More

State of the Nation

Sandy Shtab, VP of Industry and State Affairs, shares policy perspectives.
Read More

Cannabis Drug Beats Opioids in Phase 3 Low Back Pain Trial

VER-01, a cannabis extract, outperformed both placebo and opioids in two late-stage clinical trials.
Read More
1 4 5 6 7 8 52
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle